Article
Inadvertent Transfer of Murine VL30 Retrotransposons to CAR-T Cells
2022-02-01
Abstract excerpt
For more than a decade genetically engineered autologous T-cells have been successfully employed as immunotherapy drugs for patients with incurable blood cancers. The active component in some of these game-changing medicines are autologous T-cells that express viral vector-delivered chimeric antigen receptors (CARs), which specifically target proteins that are preferentially expressed on cancer cells. Some of thes...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d18cc253-b6dd-5f6e-b3b8-e2e30be921a2
- DOI
- 10.1101/2022.02.01.478686
